Aptevo Therapeutics Inc. — Director's Dealing 2019

Jun 11, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2019-06-10

Reporting Person: Kunz Barbara Lopez (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-06-10	Common Stock	P	10000	$0.8481	Acquired	10000	Direct